Digestio Aparatua

2019

1. (Pro)renin receptor expression increases throughout the colorectal adenoma—Adenocarcinoma sequence and it is associated with worse colorectal cancer prognosis

   Cancers, Vol. 11, Núm. 6

2. Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results from the ENEIDA Registry

   Inflammatory Bowel Diseases, Vol. 25, Núm. 11, pp. 1862-1870

3. Altered expression of renin-angiotensin system receptors throughout colorectal adenoma-adenocarcinoma sequence

   International Journal of Medical Sciences, Vol. 16, Núm. 6, pp. 813-821

4. Analysis of a 6-mirna signature in serum from colorectal cancer screening participants as non-invasive biomarkers for advanced adenoma and colorectal cancer detection

   Cancers, Vol. 11, Núm. 10

5. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

   Therapeutic Advances in Gastroenterology, Vol. 12

6. Autoamputation of a polypoid carcinoma of the rectum

   Gastroenterologia y Hepatologia, Vol. 42, Núm. 8, pp. 486-487

7. Autoimmune hepatitis and coeliac disease. Simultaneous onset of both diseases

   Gastroenterologia y Hepatologia, Vol. 42, Núm. 6, pp. 391-392

8. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study

   Journal of Crohn's & colitis, Vol. 13, Núm. 12, pp. 1492-1500

9. Clinical presentation, diagnosis and staging of cholangiocarcinoma

   Liver International, Vol. 39, Núm. S1, pp. 98-107

10. Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients

    Digestive Diseases and Sciences, Vol. 64, Núm. 3, pp. 846-854

11. Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU

    Alimentary Pharmacology and Therapeutics, Vol. 49, Núm. 4, pp. 419-428

12. Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease

    Journal of Crohn's and Colitis, Vol. 13, Núm. 11, pp. 1380-1386

13. Endometriosis-associated ovarian cancer: What have we learned so far?

    Clinica Chimica Acta, Vol. 493, pp. 63-72

14. Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn’s disease patients: the Practicrohn study

    Expert Review of Gastroenterology and Hepatology, Vol. 13, Núm. 8, pp. 807-813

15. Endoscopic surveillance after colonic polyps and colorrectal cancer resection. 2018 update

    Gastroenterologia y Hepatologia, Vol. 42, Núm. 3, pp. 188-201

16. EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain

    Therapeutic Advances in Gastroenterology, Vol. 12

17. Favorable Outcomes after Liver Transplantation with Normothermic Regional Perfusion from Donors after Circulatory Death: A Single-center Experience

    Transplantation, Vol. 103, Núm. 5, pp. 938-943

18. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease

    Therapeutic Advances in Gastroenterology, Vol. 12

19. Gene Expression Signature in Surgical Tissues and Endoscopic Biopsies Identifies High-Risk T1 Colorectal Cancers

    Gastroenterology, Vol. 156, Núm. 8, pp. 2338-2341.e3

20. Granulocyte–monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis

    Scandinavian Journal of Gastroenterology, Vol. 54, Núm. 4, pp. 459-464